Evelo Biosciences Inc. (EVLO) Prices 4.5M Share Common Offering at $15/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St climbs after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
After-Hours Stock Movers 01/28: (KOSS) (GME) (NVAX) Higher; (EVLO) (ADMP) (JNP) Lower (more...)
January 28, 2021 6:00 PM ESTToday's After-Hours Stock Movers:
Koss Corporation (NASDAQ: KOSS) 47.9% HIGHER; Robinhood will again allow limited trades
GameStop Corp. (NYSE: GME) 35% HIGHER; Robinhood will again allow limited trades
Novavax, Inc. (Nasdaq: NVAX) 29% HIGHER; announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical... More
Evelo Biosciences Inc. (EVLO) Announces $50M Proposed Public Offering of Common Stock
January 28, 2021 4:33 PM ESTEvelo Biosciences, Inc. (Nasdaq: EVLO) (Evelo), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that it intends to offer and sell, subject to market and other conditions, $50 million of its common stock in an underwritten public offering. Evelo expects to grant the underwriters a 30-day option, solely to cover over-allotments, if any, to purchase up to an... More
